Roger L. Hawley
Chief Executive Officer and DirectorRoger L. Hawley
Roger L. Hawley is one of our co-founders and has served as our Chief Executive Officer and as a member of our board of directors since August 2006. From January 2006 to August 2006, Mr. Hawley served as a consultant to CG Pharma, Inc. From August 2003 to January 2006 he served as Executive Vice President, Commercial and Technical Operations for InterMune, Inc., a biopharmaceutical company focused on therapies in hepatology and pulmonology. From October 2002 to July 2003, Mr. Hawley was t... |
|
 |
Stephen J. Farr, Ph.D.
President and DirectorStephen J. Farr, Ph.D.
Stephen J. Farr, Ph.D. is one of our co-founders and has served as our President and as a member of our board of directors since our inception in May 2006. From May 2006 to August 2006, Dr. Farr also served as our Chief Executive Officer and since August 2006, Dr. Farr has served as our Chief Operating Officer. From 1995 to August 2006, Dr. Farr held positions of increasing responsibility within pharmaceutical sciences and research and development at Aradigm Corporation, and he served mos... |
|
|
Ann D. Rhoads
Executive Vice President and Chief Financial OfficerAnn D. Rhoads
Ann D. Rhoads has served as our Executive Vice President, Chief Financial Officer, Treasurer and Secretary since March 2010. From 2000 to December 2009, Ms. Rhoads was the Chief Financial Officer and Senior Vice President for Premier, Inc., a healthcare service company, where she had responsibility for all areas of financial management, strategic planning, business development, information technology, and ethics and compliance. From August 1998 to 2000, Ms. Rhoads served as Vice President... |
|
|
Cynthia Y. Robinson
Chief Development OfficerCynthia Y. Robinson
Cynthia Y. Robinson, Ph.D., has served as our Chief Development Officer since April 2008, after consulting for us from April 2007 to April 2008. From November 2004 to July 2007, Dr. Robinson served as Senior Vice President, Development Operations at InterMune, Inc. From April 1989 to August 2004, Dr. Robinson held positions of increasing responsibility at Elan Pharmaceuticals, Inc., serving most recently as Vice President, Project Management, where she oversaw a portfolio of 14 global dev... |
|
|
R. Scott Shively
Executive Vice President and Chief Commercial OfficerR. Scott Shively
R. Scott Shively has served as our Chief Commercial Officer since November 2012. From 2009 to November 2012, Mr. Shively was the vice president - global commercial disease area lead for pain for Pfizer, Inc, where he had global commercial leadership responsibility for Pfizer's primary care pain franchise, as well as for all pain pipeline products, and was the lead interface for Pfizer's Pain discovery research unit.. Also while at Pfizer, Mr. Shively was heavily involved in the establishm... |
|
|
Stephen H. Jenner
Vice President, MarketingStephen H. Jenner
Stephen H. Jenner has served as our Senior Director of Marketing since July 2008. From November 2007 to July 2008, Mr. Jenner served as the Senior Vice President of Client Services at MedAccess Communications, an advertising agency specializing in the pharmaceutical industry. From June 2005 to November 2007, Mr. Jenner served as the Senior Director of Marketing for Valeant Pharmaceuticals International, a publicly-held pharmaceutical company, where he led the Neurology Marketing Departmen... |
|
|
Bret E. Megargel
Vice President, Corporate DevelopmentBret E. Megargel
Bret E. Megargel is one of our co-founders and has served as our Vice President of Corporate Development since August 2006. From December 2005 to August 2006, Mr. Megargel served as a consultant to CG Pharma, Inc. From January 2005 to August 2007, Mr. Megargel served as Vice President of Planet Technologies, Inc., an allergy products company, where he was responsible for the general management of the company’s Allergy Free business. From 2002 to December 2004, Mr. Megargel served as Vice ... |
|
|
Edward F. Smith, III, Ph.D., RAC
Vice President, Regulatory Affairs and Product Quality/SafetyEdward F. Smith, III, Ph.D., RAC
Edward F. Smith III, Ph.D., RAC, has served as our Vice President, Regulatory Affairs and Safety since October 2008. From April 2007 to October 2008, he was our Senior Director, Regulatory Affairs. From July 2006 to April 2007, he was the Senior Director, Regulatory Affairs at Connetics, a specialty pharmaceutical company focused on the development and commercialization of innovative therapeutics for the dermatology market. From October 2004 to July 2006, he was the Director, Regulatory A... |
|
|
Mark R. Thompson
Vice President, Sales and Managed MarketsMark R. Thompson
Mark R. Thompson has served as our Vice President, Sales and Managed Markets since April 2008. From January 2006 to July 2007, Mr. Thompson served as Vice President, Sales of Valeant Pharmaceuticals International, a multinational specialty pharmaceutical company, where he led both the hepatology and neuroscience sales teams, as well as management of sales operations, analytics, and training. From March 2004 to December 2005, Mr. Thompson was the Vice President, Sales at InterMune, Inc., a... |
|
|
John J. Turanin
Vice President and General Manager, Zogenix TechnologiesJohn J. Turanin
John J. Turanin is one of our co-founders and has served as our Vice President and General Manager, Zogenix Technologies since August 2010 and prior to that as our Vice President, Operations since our inception in May 2006. From 1997 to April 2006, Mr. Turanin served as Vice President, Corporate Planning and Program Management and held positions as Senior Director of Program Management, Director of New Product Planning, and Director of Respiratory Products Business Unit at Aradigm Corporation, a... |
|
|
